Literature DB >> 10951583

The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain.

K S Erdmann1, J Kuhlmann, V Lessmann, L Herrmann, V Eulenburg, O Müller, R Heumann.   

Abstract

Mutations of the tumor suppressor protein APC (Adenomatous Polyposis Coli) are linked to familiar and sporadic human colon cancer. Here we describe a novel interaction between the APC protein and the protein tyrosine phosphatase PTP-BL carrying five PDZ protein-protein interaction domains. Exclusively, the second PDZ domain (PDZ2) of PTP-BL is binding to the extreme C-terminus of the APC protein, as determined by yeast two-hybrid studies. Using surface plasmon resonance analysis we established a dissociation constant (K(D)) of 8.1 x 10(-9) M. We find that a naturally occurring splice insertion of five amino acids (PDZ2b) abolishes its binding affinity to the APC protein. The in vivo interaction between PTP-BL and the APC protein was shown by coprecipitation experiments in transfected COS cells. Furthermore, in cultured epithelial Madine Carnine Kidney cells the subcellular colocalization was demonstrated for the nucleus and also for the tips of cellular extensions. The interaction of the APC protein with a protein tyrosine phosphatase may indirectly modulate the steady state levels of tyrosine phosphorylations of associated proteins, such as beta-catenin playing a major role in the regulation of cell division, migration and cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951583     DOI: 10.1038/sj.onc.1203725

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis.

Authors:  Lutz Herrmann; Thomas Dittmar; Kai S Erdmann
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

Review 2.  PDZ domains-glue and guide.

Authors:  Marco van Ham; Wiljan Hendriks
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

3.  Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.

Authors:  Carolina Castilla; M Luz Flores; José M Conde; Rafael Medina; Francisco J Torrubia; Miguel A Japón; Carmen Sáez
Journal:  Clin Exp Metastasis       Date:  2012-01-25       Impact factor: 5.150

4.  The interaction of PTP-BL PDZ domains with RIL: an enigmatic role for the RIL LIM domain.

Authors:  Lieke C J van den Berk; Marco A van Ham; Mariska M te Lindert; Tine Walma; Jan Aelen; Geerten W Vuister; Wiljan J A J Hendriks
Journal:  Mol Biol Rep       Date:  2004-12       Impact factor: 2.316

5.  [Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines].

Authors:  O A Gur'ianova; A A Sablina; P M Chumakov; E I Frolova
Journal:  Mol Biol (Mosk)       Date:  2005 Sep-Oct

6.  Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein.

Authors:  F Zhang; R L White; K L Neufeld
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 7.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

8.  Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.

Authors:  Mariana Brocardo; Inke S Näthke; Beric R Henderson
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

9.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 10.  Nuclear APC.

Authors:  Kristi L Neufeld
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.